RESUMO
No disponible
No disponible
Assuntos
Masculino , Adulto , Humanos , Amiodarona/efeitos adversos , Paralisia Periódica Hipopotassêmica/induzido quimicamente , Tireotoxicose , Fibrilação Atrial/tratamento farmacológicoRESUMO
No disponible
Assuntos
Masculino , Feminino , Idoso , Humanos , Hemorragia Cerebral/induzido quimicamente , Ginkgo biloba/efeitos adversos , Aspirina/uso terapêuticoAssuntos
Bacteriemia/diagnóstico , Citrobacter , Infecções por Enterobacteriaceae/diagnóstico , Pneumonia Bacteriana/diagnóstico , Idoso , Idoso de 80 Anos ou mais , Bacteriemia/microbiologia , Citrobacter/isolamento & purificação , Infecções Comunitárias Adquiridas/diagnóstico , Infecções Comunitárias Adquiridas/microbiologia , Infecções por Enterobacteriaceae/microbiologia , Feminino , Humanos , Pneumonia Bacteriana/microbiologiaRESUMO
No disponible
Assuntos
Idoso de 80 Anos ou mais , Idoso , Feminino , Humanos , Citrobacter , Bacteriemia , Pneumonia Bacteriana , Infecções Comunitárias Adquiridas , Infecções por EnterobacteriaceaeRESUMO
OBJECTIVES: Describing the bacteriological map of the urinary tract infections (UTI) in our area including intra and extrahospitalized patients during 1997. MATERIAL AND METHODS: Descriptive-retrospective study, 12,937 urocultives were carried out in our laboratory: 847 from hospitalized patients and 12,090 from 15 Health Centres. RESULTS: 1,527 positive cultures (12.6%) were obteined from Health Centre patients and 215 (25.3%) from hospitalized patients. Bacterial distribution was similar between them, except enterocci and negative coagulase estafilococci which were more frequent in hospitalized patients. We have observed a high prevalence of Enterobacter sp. (4%) and Pseudomonas sp. (4%) which disagrees with other studies. E.coli (presents in 69% of the positive urocultives) was widespread resistant to quinolones, pipemidic acid and nitrofuration, while it had high sensitivity to fosfomicin, cephuroxim and amoxicilin-clavulanic acid. CONCLUSIONS: The level of resistance to the quinolones is considerable in our area, so clinicians should give them up in empirical treatment and use fosfomicine, cephuroxime or amoxicilin-clavulanic acid.